Hanmi Pharmaceutical, Daewoong Pharmaceutical, and Chong Kun Dang are competing for no.1 place on prescription drug market

According to the analysis result of data from UBIST by Tongyang Securities, Hanmi Pharmaceutical ranked no.1 in prescription drug sales in the first half of the year with 182.8 billion won, followed by Daewoong Pharmaceutical 182.7 billion won and Chong Kun Dang 181.8 billion won. These three companies are competing for no.1 place on prescription drug market.

Yuhan Corporation recorded 172.7 b...